India's preferred Personal finance destination
Home Shares News Centre F&O Mutual Funds IPO Portfolio Commodity Loans Financial Planning Insurance About Us
Markets Companies Research Industries E-Mail Page
Wealth Tracker      Tax Corner NRI Centre Chat Masala Feedback

my Last 5 Scrips
Company BSE Price(Rs) % Chg
Larsen & 1309.75 5.60
Tata Mot 265.80 3.28
State Ba 305.00 0.99
Sun Phar 623.60 0.05
Infosys 1396.50 2.43
Clear All Clear Last
NSE Live
Nifty Live Prices
Live Quotes
Top Gainers/Losers
Top 10 Turnover
No Delivery Stocks
BSE Live
BSE30 Live Prices
Live Quotes
Top Gainers/Losers
Top 10 Turnover
No Delivery Stocks
Market Pulse
FII Activity
Mutual Fund Activity
Results Watch
Results Calendar
Results Announced
IPO Watch
Recent News
Broker Research
Research Tutorial
Discussion Forum
Research Reports
News Watch
Sector Watch
Economy Watch
News-Lupin Limited
Lupin Limited
Sector:Pharmaceuticals Pharmaceuticals - Bulk Drugs
Market Lot: 1Face Value: 2ISIN Demat: INE326A01037
QuotesSnapshotChartsFinancialsResearchRecent News
Peer GroupAGM/AMMF HoldingDiscussion ForumBSE/NSE NoticesBSE/NSE Deals

Corporate News
30-Jul-2018       Lupin's Mandideep facility gets approval from EDQM IRIS
27-Jul-2018       Lupin launches generic Desoximetasone topical spray IRIS
19-Jul-2018       Lupin receives tentative USFDA approval for generic Tadalafil tablets IRIS
16-Jul-2018       Lupin's Goa facility gets approval from UK-health regulator IRIS
12-Jul-2018       Lupin receives nod for generic Nitrofurantoin capsules IRIS
11-Jul-2018       Lupin-Boehringer ink pact to co-market 2 oral anti-diabetic drugs IRIS
10-Jul-2018       Lupin appoints Yashwant Mahadik as President IRIS
09-Jul-2018       Lupin gets nod for generic Hydroxychloroquine Sulfate tablets IRIS
29-Jun-2018       Lupin tie-up with European Association of Urology IRIS
29-Jun-2018       Lupin, MCGM unite to launch anti-TB campaign in Mumbai IRIS
28-Jun-2018       Lupin, Mylan partner to commercialise Etanercept biosimilar IRIS
18-Jun-2018       Lupin, Nichi-Iko in pact for commercialisation of Etanercept in Japan IRIS
14-Jun-2018       Lupin receives USFDA approval for pregnancy prevention tablets IRIS
14-Jun-2018       Lupin launches generic Tobramycin inhalation solution in US IRIS
04-Jun-2018       Lupin receives approval for generic Nystatin, Triamcinolone Acetonide cream IRIS
04-Jun-2018       Lupin launches generic Methylergonovine Maleate tabs in US IRIS
31-May-2018       Lupin launches Solosec 2g oral granules in US IRIS
25-May-2018       Lupin submits MAA for Etanercept Biosimilar in Europe IRIS
15-May-2018       Lupin turns to loss in Jan-Mar quarter on one-time charge IRIS
14-May-2018       Lupin's Nagpur facility USFDA inspection concluded with no observations IRIS



Home | Shares | F&O | Mutual Funds | Loans | Insurance | News Centre
Wealth Tracker | Tax Corner | NRI Centre | Search in myiris | Advertise
All rights reserved. IRIS Business Services Limited